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ABSTRACT 
Objectives: To study the toxicity effects of coal fly ash nanoparticles-induced acute dermal toxicity in Wistar albino rats. 
Methods: Acute dermal toxicity studies for coal fly ash nanoparticles (CFA-NPs) were conducted in Wistar albino rats. A single dose of various 
concentrations of CFA-NPs or vehicle was applied on the dorsal layer after shaving. Animals were observed for 14 days. Parameters like body 
weight, feed intake and histopathology were studied. 
Results: The CFA-NPs treated rats did not show any abnormal clinical signs. The body weight was not significantly altered when compared with the 
control group. Treatment with CFA-NPs showed mild to severe histological changes in all organs with increase dose-related manner in 
concentrations of CFA-NPs treated groups. The acute dermal LD50 of CFA-NPs was found to be greater than 2000 mg/kg body weight (bw) for rats. 
Conclusion: Dermal acute treatment with CFA-NPs can induce mild to significant dose-dependent histological changes in biological organs. 
Keywords: Coal fly ash nanoparticles, Dermal toxicity, Histopathology. 
 
INTRODUCTION 
Acute toxicity refers to adverse effects occurring following a single 
exposure to a substance within 24 h. Generally it is necessary to identify 
the lethal dose 50 (LD50) value for environmental and occupational 
exposure particles, it is due to their intended biological activity and toxic 
mode of action, as well as daily exposure to the particles via multiple 
roots such as, dermal and/or inhalation. The purpose of the acute 
toxicity studies was to obtain information on the biologic activity of a 
given substance and gain insight into its mechanism of action. Long term 
studies like sub-acute and sub-chronic studies usually start with a dose-
finding exercise under acute conditions. Nanoparticles (NPs) possess 
dramatically different physicochemical properties compared to fine 
particles of the same composition. Smaller the size of the particle, the 
greater is its surface area to volume ratio, and the higher its chemical and 
biological reactivity [1]. 
Coal fired boilers are generally used in power stations to generate 
electricity due to low cost and abundance of this fuel. Combustion of 
coal generates large amount of particulate matter (PM) in to the 
atmosphere which are formed by mineral transformation during high-
temperature combustion process. Coal fly ash particulate matter (CFA-
PM) emissions were controlled by several methods, but these control 
measures are not completely effective. CFA-PM can still remain a 
significant fraction of the overall particle exposure for power plant 
workers and highly impacted communities. The efficiencies of the 
filtering devices fail within the size of PM matter below 100 nm [2]. 
These ultra fine particles escapes and get dispersed in air [3]. Human 
health impacts of CFA (PM 0.1) released in to the atmosphere is the 
major health concern in developing countries. Especially exposure to 
combustion derived nanoparticles (CD-NPs) has increased 
dramatically within the past century. The greater surface areas of ultra 
fine CD-NPs compared with larger particles with the same chemical 
compositions make them more environmentally active with respect to 
biouptake and associated diseases [4-6].  
Information is lacking in describing the human health and 
environmental implications of coal fly ash nanoparticles (CFA-NPs). 
Data is needed for cutaneous analysis after CFA-NPs exposure that 
could occur during the work conditions and also for close living 
communities. Currently, there is no information is available 
regarding whether nanoparticles can be absorbed through skin and 
cross the skin’s stratum corneum barrier or whether systemically 
administered particles can accumulate in dermal tissue. The 
tendency of CFA-NPs to traverse the skin is a primary determinant 
of its dermatotoxic potential. That is, the nanoparticles should 
penetrate the uppermost stratum corneum layer in order to gain 
entrance to the viable epidermis and exert toxicity in the lower cell 
layers from then to systemic circulation [7]. The nano sized particles 
are then able to penetrate through the basic biological organs and 
leads to inflammation of tissues and also alters the cellular redox 
balance towards oxidation, leading to cell death [8]. 
Elemental composition of CFA varies with the type of the Coal and 
combustion. Like other engineered nanoparticles, CFA-NPs 
agglomerate readily and move into the accumulation mode which 
decreases the particle number but probably leaves the surface area 
dose unaffected. NPs has ability to penetrate through the skin and 
cause inflammation and cell death and also, In the case of insoluble 
CDNPs, have potential to escape from the site of deposition and 
translocate to the blood and to other target organs [9]. CFA-NPs emits 
large amounts of PM into the atmosphere has adverse effects on living 
organisms when exposed directly to the skin. It is previously reported 
that CFA-NPs contains several toxic heavy metals present in it [10].  
In this report, we have estimated the quantitative relationship 
between dermal exposure to CFA-NPs and it toxic response. A basic 
tenant of toxicity is that the degree of harm is directly related to the 
amount of exposure. There is no information on dermal exposure 
toxicity of CFA-NPs. Therefore we investigated the potential acute 
toxicity, providing useful information for assessing the toxicological 
relevance of CFA-NPs. Tests were carried out according to the OECD 
guidelines. The dermal exposures to various concentrations of CFA-
NPs were extensively studied. The collection and characterization of 
CFA-NPs were previously done by Sambandam et al. (2014) [10]. 
The same collected CFA-NPs were used in the present study. 
MATERIALS AND METHODS 
Animal ethics 
This study was approved by an Institutional Animal Ethical 
committee (IAEC) and was executed according to the approved 
methodology (XV/VELS/PCOL/12/2000/CPSCEA/IAEC/30.10.13) 
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Experimental conditions 
The acute dermal toxicity was conducted as per the OECD guidelines 
402 [11]. Wistar albino rats of female sex weighing about 180-250 g 
were used for experiments. The females used were nulliparous and 
non-pregnant. Animals were divided in to 6 Groups (n=6) as follows: 
Group I (control group), Group II (vehicle control), Group III (500 
mg/kg bw of CFA-NPs), Group IV (1000 mg/kg bw of CFA-NPs), 
Group V (1500 mg/kg bw of CFA-NPs) and Group VI (2000 mg/kg 
bw of CFA-NPs). 
Approximately 24 h before the test, the hair coat was removed by 
closely shaving the dorsal area of trunk of the animals. Care was taken 
to avoid abrading the skin which may alter its permeability. The 
various concentrations of CFA-NPs 500, 1000, 1500 and 2000 mg/kg 
bw were mixed with saline and made in to a paste and applied on the 
shaved area. Then the skin area was covered pourous gauze dressing 
and non-irritating tape for a period of 24 h, whereas for control 
groups, gauze moistened with physiological saline was applied and 
held in contact with skin similar way as the treatment groups. Animals 
were observed within 30 min, 4 and 24 h after the removal of films 
and kept under observation for 14 d. Total individual feed intake, 
weight of the animals was determined on the day of application of 
various concentrations of CFA-NPs and weekly thereafter. The animals 
were observed for changes in skin, eyes and mucous membranes, 
behavioural patterns, diarrhea, salivation and termors. Mortality was 
recorded during the course of study. At the end of the study, animals 
were weighed, sacrificed and subjected to histopathology. 
Histopathological study 
Animals, in each group were sacrificed after fasting overnight upon 
termination of their regular feeding. Organs like lung, liver, kidney, 
spleen and skin were excised and the organs were fixed in 10% 
formalin saline. After fixing for 24 h the tissues were cleared and 
embedded to paraffin wax (60-62 °C). Embedded tissue was made in 
to the paraffin block. Using microtome embedded block was cut in 
uniform sections of 4-5 μm thickness and stained with hematoxylin 
and eosin by routine procedures. First dewax with xyline and fix 
slides in Isopropyl alcohol for 10 min and wash the slides with 
water. Add hematoxylin for few min and again wash it with water. 
Dip the slides once in 1% acid alcohol (Alcohol-70 ml, distilled 
water-30 ml, mix and discard 1.0 ml, add 1 ml of concentrated HCl) 
and wash it with water followed by Ammonia water (distilled water 
50 ml, Liquid ammonia-3 drops). Finally add Eosin and leave it for 1 
min and wash it with water and dry and mount. The stained sections 
were examined for pathological changes at desired magnification. 
Statistics 
The results for body weight were presented as the mean±standard 
deviation (SD). Comparisons were made between control and 
treatment groups using one way ANOVA followed by Dunnett’s test 
using SPSS program (Version 11.5). Values of P ≤ 0.05 were 
regarded as statistically significant. 
RESULTS  
Effects of CFA-NPs-induced acute dermal toxicity in rats 
Changes in general behavior, food intake, body weight and 
histopathology parameters are critical for evaluating the impact of any 
test compound on the biological system. The acute dermal toxicity for 
various concentrations of CFA-NPs was tested. There were no 
appreciable clinical signs throughout the observation period of 14 d. 
After removal of patch some changes were observed in the treated 
area of skin, like inflammation and irritation in all treated 
concentrations of CFA-NPs. There were no changes observed in eyes, 
mucous membranes and behavioral pattern. There was no mortality 
throughout the observation period. Both control and the treated group 
were observed to consume the entire amount of food (10 g/rat/day). 
Also, there were no significant (P ≥ 0.05) changes in body weight in the 
treatment group when compared to the respective control group rats 
as shown in table 1. The result of acute toxicity study indicates that the 
LD50
Histopathological observations in different organs 
 of the CFA-NPs is greater than 2000 mg/kg bw. 
Liver 
The histology of liver sections is shown in fig 1. The liver section of 
rats treated with various concentrations of CFA-NPs showed some 
mild to severe damage in all treated concentrations of CFA-NPs 
when compared to the control. Both the control and vehicle control 
section showed normal liver architecture. At lower concentration, 
500 mg/kg bw of CFA-NPs treated section shows mild central vein 
dilatation and congestion. In 1000 mg/kg bw of CFA-NPs treated 
rats the section showed congested central vein dilatation, sinusoidal 
dilatation and inflammatory infiltration. At 1500 mg/kg bw of CFA-
NPs treated group; the section showed congested central vein 
dilatation and sinusoidal widening. At higher dose of 2000 mg/kg 
bw of CFA-NPs treated group, the section showed focal bile duct 
proliferation (Nut-meg liver), increased central vein congestion and 
inflammatory infiltration. The histopathology of the tissues showed 
considerable damage in all concentration of CFA-NPs treated groups 
when compared to the control. 
 
 
Fig. 1: Liver sections of rats dermally treated with various concentrations of CFA-NPs for 14 days (a-normal control, b-vehicle control, c-
500 mg/kg bw of CFA-NPs, d-1000 mg/kg bw of CFA-NPs, e-1500 mg/kg bw of CFA-NPs and f-2000 mg/kg bw of CFA-NPs) 
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Table 1: Effect of CFA-NPs treatment on body weight (g) in rats during acute dermal toxicity study. None of these values are significant 
when compared to the control (P ≥ 0.05). Values are expressed as mean±SD 
No. of 
days 
Control Vehicle Control 500 mg/kg bw of  
CFA-NPs 
1000 mg/kg bw of  
CFA-NPs 
1500 mg/kg bw of  
CFA-NPs 
2000 mg/kg bw of  
CFA-NPs 
Day 0 188.00±4.47 192.33±6.28 192.00±6.98 193.83±7.83 194.00±9.71 191.66±7.84 
Day 7 192.08±4.34 196.66±6.28 196.75±7.18 198.91±6.74 198.50±9.62 196.33±7.63 
Day 14 197.33±3.73 201.75±6.16 201.08±7.28 203.46±7.05 202.91±9.42 200.91±7.67 
 
Kidney 
The kidney sections of rats treated with various concentrations of 
CFA-NPs showed mild to severe tissue damage in all treated 
concentrations when compared to control was shown in fig. 2. Both 
the control sections showed normal glomeruli with normal tubules. 
At lower concentration of 500 mg/kg bw of CFA-NPs treated tissue 
sections showed thick walled congested blood vessels, mild hyper 
cellular glomeruli and congestion of distal convoluted tubule. At 
1000 mg/kg bw of CFA-NPs treated rats; the section showed 
congested tubule and mild hyper cellular glomeruli. At higher 
concentration of 1500 mg/kg bw of CFA-NPs treated sections 
showed dilated distal convoluted tubule with congestion and 
increased cellular glomeruli. At 2000 mg/kg bw of CFA-NPs treated 
kidney sections showed congested tubule, dilated distal convoluted 
tubule with congestion and increased cellular glomeruli. On the 
whole, the histopathology of kidney tissues showed mild damages at 
lower concentration of CFA-NPs and severe damage at higher dose 
when compared to the control groups.  
Spleen 
The spleen sections of rats treated with various concentrations of 
CFA-NPs showed severe damage of tissues in all the treated 
concentrations when compared to control groups as shown in fig. 3. 
Both the control sections show normal spleen. At lower 
concentration (500 mg/kg bw of CFA-NPs) the spleen section 




Fig. 2: Kidney sections of rats dermally treated with various concentrations of CFA-NPs for 14 days (a-normal control, b-vehicle control, c-
500 mg/kg bw of CFA-NPs, d-1000 mg/kg bw of CFA-NPs, e-1500 mg/kg bw of CFA-NPs and f-2000 mg/kg bw of CFA-NPs) 
 
 
Fig. 3: Spleen sections of rats dermally treated with various concentrations of CFA-NPs for 14 days (a-normal control, b-vehicle control, c-
500 mg/kg bw of CFA-NPs, d-1000 mg/kg bw of CFA-NPs, e-1500 mg/kg bw of CFA-NPs and f-2000 mg/kg bw of CFA-NPs) 
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The rats treated with 1000 mg/kg bw of CFA-NPs showed congested 
spleen with distorted red pulp and normal white pulp. At 1500 
mg/kg bw of CFA-NPs treated spleen section showed extensive 
congestion and prominent red pulp. At higher dose 2000 mg/kg bw 
of CFA-NPs treated group showed spleen with areas of congestion 
and thick walled blood vessels. The histopathology of spleen tissues 
showed very severe damage in all treated concentration of CFA-NPs. 
In all sections there was appearance of red pulp; this was not found 
in the control groups. In all treated concentrations of CFA-NPs there 
were notable changes found in the tissues when compared to the 
control. 
Skin  
The histology of skin sections are shown in fig. 4. The skin sections 




Fig. 4: Skin sections of rats dermally treated with various concentrations of CFA-NPs for 14 days (a-normal control, b-vehicle control, c-
500 mg/kg bw of CFA-NPs, d-1000 mg/kg bw of CFA-NPs, e-1500 mg/kg bw of CFA-NPs and f-2000 mg/kg bw of CFA-NPs) 
 
In control groups; the skin section showed normal histology. At lower 
concentration of 500 mg/kg bw of CFA-NPs treated skin section 
showed mild hyperkeratosis and increased hair shafts with squamous 
metaplasia. In 1000 mg/kg bw of CFA-NPs treated skin sections 
showed mild hyperkeratosis, papillomatosis and increase in hair 
follicles. In 1500 mg/kg bw of CFA-NPs treated groups section showed 
proliferation of numerous hair shafts. At higher concentration (2000 
mg/kg bw of CFA-NPs) the skin section showed mild inflammation, 
increased pilosebaceous units, increased hyperkeratosis and 
prominent hair shafts. Overall, the histopathology of the skin showed 
severe damage in all treated concentrations of CFA-NPs when 
compared to the untreated control groups. Since the CFA-NPs is 
treated dermally; there was significant damage observed in the skin 
tissues in all treated concentrations of CFA-NPs. 
DISCUSSION 
A study of acute toxicity by the dermal route and determination of a 
LD50
Histopathology of tissues revealed mild to marked cellular changes 
upon dermal administration to various concentrations of CFA-NPs in 
rats. There were severe histological changes were observed in all the 
organs, in the treated concentrations of CFA-NPs. The magnitude 
and manifestation depends on the health status of experimental 
animals. Histopathological changes in the tissues of animals exposed 
to various chemical agents have been reported [12,13]. There were 
no acute dermal toxicity studies reported previously in relation to 
CFA. In control groups the tissues of liver, kidney, spleen and skin 
showed normal architectural pattern without any changes. Dermal 
treatment with various concentrations of CFA-NPs showed mild to 
severe histological changes in the tissues of liver, kidney, spleen and 
skin. At higher concentrations; the CFA-NPs dermally treated group 
organ tissues showed more damage when compared to the lower 
concentration treated groups. The occurrence of changes in all CFA-
NPs treated groups is due to toxic elements present in the CFA-NPs. 
Changes in the histopathology of the tissues is due to some toxic 
metals enters through the skin barriers and may be transported 
through blood, resulting in organ damage. In comparison with other 
tested organs, the CFA-NPs treated skin showed severe effect. Since 
the CFA-NPs were treated dermally, there was direct exposure of 
CFA-NPs in the dermal layers, thus the dermal tissues showed 
severe histological changes when compared to other organs.  
 provides an estimate of the relative toxicity of a substance by 
the dermal route of exposure and they may serve as a basis for 
classification and labeling. The LD50 is defined as the statistically 
derived dose that, when administered in an acute toxicity test, is 
expected to cause death in 50% of the treated animals in a given 
period. It is an initial step in establishing a dosage regimen in sub 
acute, sub chronic and other studies. It may provide information on 
dermal adsorption and the mode of toxic action of a substance by this 
route. During acute dermal toxicity studies, no mortality was observed 
at any stage of the study. The skin inflammation is caused by exposure 
to CFA-NPs. The skin inflammation was observed in all treated 
concentrations of CFA-NPs and no changes were observed in control 
groups. In comparison with control groups, there was no significant 
changes were observed in body weight of various concentrations of 
CFA-NPs treated groups and also in vehicle control groups. 
The CFA-NPs are smaller than the size of the skin pores, when CFA-
NPs nanomaterials are applied topically to the skin, they must be 
able to penetrate through the viable epidermal layers and 
epidermal-dermal junction (basement membrane) to gain access to 
the capillaries within the papillary layer of the dermis in order to get 
into the systemic circulation [7]. There is only few information 
regarding dermally induced NPs toxicity but no literature pertaining 
to the absorption of CFA-NPs through skin. CFA-NPs have several 
toxic elemental compositions present in it. Due to the possibility of 
chemical interactions between the elements, the effects of dermal 
application of NPs with other NPs are largely unknown. The 
estimated risk of two or more metal particles is not a simple additive 
process. Particle surface plays a critical role in toxicity as it makes 
contact with cells and biological organs. The presence of transition 
metals [14] on nanoparticles surfaces leads to the generation of ROS 
and the induction of inflammation in cells [15], reported that the 
spherical shaped particles with diameter between 750 nm and 6 
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microns penetrate through the hair follicles of the skin with 
maximum penetration depth of more than 2.4 mm. NPs can also 
penetrate through the skin when the skin is flexed. Broken skin 
facilitates the entry of a wide range of larger particles around 500 
nm to 7 nm in diameter [5]. The mechanical deformation is capable of 
transporting particles through the stratum corneum and into the 
epidermis and dermis. The dermis has a rich supply of blood and 
macrophages, lymph vessels, dendritic cells and nerve endings [5]. 
Therefore, the NPs that penetrate through the stratum corneum and 
into the epidermis and dermis are potentially available for recognition 
by the immune system. Tinkle et al. (2003) [16] provides compelling 
evidence that NPs could penetrate the skin in demonstrating 
epidermal and dermal penetration by fluorescent microspheres (0.5-
1.0 µm) in human skin in an in vitro flexed skin model. 
CONCLUSION  
Acute dermal treatment with various concentrations of CFA-NPs 
from coal-fired power plants may induce mild to significant dose-
dependent pathological changes in all the observed biological 
organs. The LD50
1. Shi H, Magaye R, Castranova V, Zhao J. Titanium dioxide 
nanoparticles: a review of current toxicological data. Part Fibre 
Toxicol 2013;10:15. 
 value for acute dermal toxicity of CFA-NPs was 
greater than 2000 mg/kg bw. The CFA-NPs treated animals did not 
show any abnormal clinical changes or mortality in treated groups. 
Single exposure to various concentrations of CFA-NPs in rats 
showed an increased susceptibility to infection in all the organs. 
Especially, more histological damage was observed on skin tissue; it 
is due to route of direct exposure to CFA-NPs. Thus, single to CFA-
NPs could cause skin inflammation in a matter of minutes or hours. 
Therefore prolonged exposure to CFA-NPs may cause serious 
damages to the peoples in the working environment and also to the 
peoples living close to the Coal fired power plants. Hence, long term 
exposure studies are warranted in the future. 
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